Rheumatoid arthritis drug shows promise against COVID-19, study finds
A drug against rheumatoid arthritis called baricitinib could potentially be repurposed to treat patients with COVID-19, according to a study
Read more
New pieces added to the molecular puzzle of rheumatoid arthritis
Walter and Eliza Hall Institute researchers have revealed new details about how joint inflammation evolves in rheumatoid arthritis, and the
Read more